poisar

Markets · News reference

8-K filing — JLL Income Property Trust, Inc.

SEC EDGARSEC EDGAR

Filed: 2026-09-04 AccNo: 0001314152-26-000179 Size: 264 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

No ticker was attached by the source feed.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncResearchandmarkets.Com

    $32 Million Exosome Therapy Market Assessment 2026: Set to Experience Massive Growth, Reaching $1.4 Billion by 2040

    The global exosome therapy market is projected to grow from $32 million in 2026 to $1.4 billion by 2040, with a CAGR of 41.1%. Key growth drivers include expanding clinical pipelines, increased regulatory filings, and rising investment in regenerative medicine. Ophthalmology and oncology represent major therapeutic areas, while Asia-Pacific is positioned as a leading market. However, challenges include inconsistent therapeutic preparations, contamination risks, and quality control complexities.

  2. Globenewswire IncResearchandmarkets.Com

    Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA

    The global drug reconstitution systems market is expected to grow at a 7.0% CAGR from $5.9 billion in 2026 to $10.8 billion by 2035, driven by expanding biologic and biosimilar pipelines, increasing demand for safer drug delivery systems, and the shift toward home healthcare and self-administered therapies. Cartridges lead the market at 50% revenue share, while prefilled syringes are expected to grow faster. Asia-Pacific is projected to achieve the fastest regional growth.

  3. Globenewswire IncSns Insider

    Drug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider

    The global drug repurposing market is projected to grow from USD 34.79 billion in 2025 to USD 50.91 billion by 2035 at a CAGR of 3.93%. North America leads with 39% market share, while Asia-Pacific shows the fastest growth at 5.02% CAGR. Small molecules dominate at 67% market share, with oncology and neurology as primary therapeutic areas. AI and machine learning are accelerating drug discovery, though intellectual property rights remain a key barrier.

  4. Globenewswire IncSns Insider

    Quick Service Restaurants (QSR) Market Surges to USD 2,462.71 Billion by 2035, at 8.75% CAGR – Report by SNS Insider

    The global Quick Service Restaurants market is projected to grow from USD 1,064.44 billion in 2025 to USD 2,462.71 billion by 2035 at an 8.75% CAGR. Digital ordering and delivery services now account for 48% of QSR sales, with online orders exceeding 120 billion globally. North America leads with 34.65% market share, while Asia Pacific emerges as the fastest-growing region at 9.96% CAGR. Major players are investing in digital innovation, mobile apps, and contactless services to capture growing consumer demand for convenience.